Chronic angiotensin-(1-7) improves insulin sensitivity in high-fat fed mice independent of blood pressure

Hypertension

Volumn 67, Issue 5, 2016, Pages 983-991

  Williams, Ian M ^a   Otero, Yolanda F ^a   Bracy, Deanna P ^a   Wasserman, David H ^a   Biaggioni, Italo ^a   Arnold, Amy C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

hypertension; insulin resistance; metabolism; obesity; renin angiotensin system

Indexed keywords

ANGIOTENSIN[1-7]; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; ANGIOTENSIN I; ANGIOTENSIN I (1-7); GLUCOSE BLOOD LEVEL; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CAPILLARY DENSITY; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE TRANSPORT; HEART RATE; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; MUSCLE FIBER MEMBRANE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SARCOLEMMA; SKELETAL MUSCLE; STEADY STATE; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; ANIMAL; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; C57BL MOUSE; CARDIOVASCULAR DISEASES; COMPLICATION; DISEASE MODEL; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; GLUCOSE CLAMP TECHNIQUE; HEART FUNCTION TEST; HEMODYNAMICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; REFERENCE VALUE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALYSIS OF VARIANCE; ANGIOTENSIN I; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE DETERMINATION; BODY COMPOSITION; CARDIOVASCULAR DISEASES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GLUCOSE CLAMP TECHNIQUE; HEART FUNCTION TESTS; HEMODYNAMICS; HYPERTENSION; INFUSIONS, SUBCUTANEOUS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; OBESITY; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; REFERENCE VALUES; RENIN-ANGIOTENSIN SYSTEM;

EID: 84961231074     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06935     Document Type: Article

References (40)

1. Kim S, Iwao H, Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000 52 11 34
2. Luther JM, Brown NJ, The renin-Angiotensin-Aldosterone system and glucose homeostasis. Trends Pharmacol Sci 2011 32 734 739. doi: 10.1016/j.tips.2011.07.006
3. Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr, Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-Analysis of randomized clinical trials. J Am Coll Cardiol 2005 46 821 826. doi: 10.1016/j.jacc.2005.05.051
4. Schindler C, Bramlage P, Kirch W, Ferrario CM, Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vasc Health Risk Manag 2007 3 125 137
5. Giani JF, Mayer MA, Muñoz MC, Silberman EA, Höcht C, Taira CA, Gironacci MM, Turyn D, Dominici FP, Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 2009 296 E262 E271. doi: 10.1152/ajpendo.90678.2008
6. Guimaraes PS, Oliveira MF, Braga JF, Nadu AP, Schreihofer A, Santos RA, Campagnole-Santos MJ, Increasing angiotensin-(1-7) levels in the brain attenuates metabolic syndrome-related risks in fructose-fed rats. Hypertension 2014 63 1078 1085. doi: 10.1161/HYPERTENSIONAHA.113.01847
7. Marcus Y, Shefer G, Sasson K, Kohen F, Limor R, Pappo O, Nevo N, Biton I, Bach M, Berkutzki T, Fridkin M, Benayahu D, Shechter Y, Stern N, Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes 2013 62 1121 1130. doi: 10.2337/db12-0792
8. Santos SH, Fernandes LR, Mario EG, Ferreira AV, Pôrto LC, Alvarez-Leite JI, Botion LM, Bader M, Alenina N, Santos RA, Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 2008 57 340 347. doi: 10.2337/db07-0953
9. Takeda M, Yamamoto K, Takemura Y, Takeshita H, Hongyo K, Kawai T, Hanasaki-Yamamoto H, Oguro R, Takami Y, Tatara Y, Takeya Y, Sugimoto K, Kamide K, Ohishi M, Rakugi H, Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice. Diabetes 2013 62 223 233. doi: 10.2337/db12-0177
10. Gupte M, Thatcher SE, Boustany-Kari CM, Shoemaker R, Yiannikouris F, Zhang X, Karounos M, Cassis LA, Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol 2012 32 1392 1399. doi: 10.1161/ATVBAHA.112.248559
11. Ayala JE, Bracy DP, Malabanan C, James FD, Ansari T, Fueger PT, McGuinness OP, Wasserman DH, Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. J Vis Exp 2011 57 3188
12. Morgan CR, Lazarow A, Immunoassay of pancreatic and plasma insulin following alloxan injection of rats. Diabetes 1965 14 669 671
13. Steele R, Wall JS, De Bodo RC, Altszuler N, Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 1956 187 15 24
14. Kraegen EW, James DE, Jenkins AB, Chisholm DJ, Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 1985 248 3 pt 1 E353 E362
15. Andrade JM, Lemos Fde O, da Fonseca Pires S, Millán RD, de Sousa FB, Guimarães AL, Qureshi M, Feltenberger JD, de Paula AM, Neto JT, Lopes MT, Andrade HM, Santos RA, Santos SH, Proteomic white adipose tissue analysis of obese mice fed with a high-fat diet and treated with oral angiotensin-(1-7). Peptides 2014 60 56 62. doi: 10.1016/j.peptides.2014.07.023
16. Winzell MS, Ahrén B, The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004 53(suppl 3 S215 S219
17. Echeverría-Rodríguez O, Del Valle-Mondragón L, Hong E, Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo. Peptides 2014 51 26 30. doi: 10.1016/j.peptides.2013.10.022
18. Fu Z, Zhao L, Aylor KW, Carey RM, Barrett EJ, Liu Z, Angiotensin-(1-7) recruits muscle microvasculature and enhances insulin's metabolic action via mas receptor. Hypertension 2014 63 1219 1227. doi: 10.1161/HYPERTENSIONAHA.113.03025
19. Gironacci MM, Adamo HP, Corradi G, Santos RA, Ortiz P, Carretero OA, Angiotensin (1-7) induces MAS receptor internalization. Hypertension 2011 58 176 181. doi: 10.1161/HYPERTENSIONAHA.111.173344
20. Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS, Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest 1997 100 530 537. doi: 10.1172/JCI119562
21. Zinker BA, Lacy DB, Bracy DP, Wasserman DH, Role of glucose and insulin loads to the exercising limb in increasing glucose uptake and metabolism. J Appl Physiol (1985) 1993 74 2915 2921
22. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M, Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 2006 29 1613 1618. doi: 10.2337/dc05-1711
23. Lorenzo C, Wagenknecht LE, Hanley AJ, Rewers MJ, Karter AJ, Haffner SM, A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010 33 2104 2109. doi: 10.2337/dc10-0679
24. Laakso M, Kuusisto J, Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol 2014 10 293 302. doi: 10.1038/nrendo.2014.29
25. Henriksen EJ, Prasannarong M, The role of the renin-Angiotensin system in the development of insulin resistance in skeletal muscle. Mol Cell Endocrinol 2013 378 15 22. doi: 10.1016/j.mce.2012.04.011
26. Coimbra CC, Garofalo MA, Foscolo DR, Xavier AR, Migliorini RH, Gluconeogenesis activation after intravenous angiotensin II in freely moving rats. Peptides 1999 20 823 827
27. Prasannarong M, Santos FR, Henriksen EJ, ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle. Biochem Biophys Res Commun 2012 426 369 373. doi: 10.1016/j.bbrc.2012.08.093
28. Bonner JS, Lantier L, Hocking KM, Kang L, Owolabi M, James FD, Bracy DP, Brophy CM, Wasserman DH, Relaxin treatment reverses insulin resistance in mice fed a high-fat diet. Diabetes 2013 62 3251 3260. doi: 10.2337/db13-0033
29. Kang L, Mayes WH, James FD, Bracy DP, Wasserman DH, Matrix metalloproteinase 9 opposes diet-induced muscle insulin resistance in mice. Diabetologia 2014 57 603 613. doi: 10.1007/s00125-013-3128-1
30. Tran LT, Yuen VG, McNeill JH, The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem 2009 332 145 159. doi: 10.1007/s11010-009-0184-4
31. Leto D, Saltiel AR, Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 2012 13 383 396. doi: 10.1038/nrm3351
32. Shiuchi T, Cui TX, Wu L, Nakagami H, Takeda-Matsubara Y, Iwai M, Horiuchi M, ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension 2002 40 329 334
33. Sano H, Kane S, Sano E, Mîinea CP, Asara JM, Lane WS, Garner CW, Lienhard GE, Insulin-stimulated phosphorylation of a Rab GTPase-Activating protein regulates GLUT4 translocation. J Biol Chem 2003 278 14599 14602. doi: 10.1074/jbc.C300063200
34. Muñoz MC, Giani JF, Burghi V, Mayer MA, Carranza A, Taira CA, Dominici FP, The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7). Regul Pept 2012 177 1 11. doi: 10.1016/j.regpep.2012.04.001
35. Muñoz MC, Giani JF, Dominici FP, Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. Regul Pept 2010 161 1 7. doi: 10.1016/j.regpep.2010.02.001
36. Santos SH, Giani JF, Burghi V, Miquet JG, Qadri F, Braga JF, Todiras M, Kotnik K, Alenina N, Dominici FP, Santos RA, Bader M, Oral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats. J Mol Med (Berl) 2014 92 255 265. doi: 10.1007/s00109-013-1087-0
37. Larance M, Ramm G, Stöckli J, van Dam EM, Winata S, Wasinger V, Simpson F, Graham M, Junutula JR, Guilhaus M, James DE, Characterization of the role of the Rab GTPase-Activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem 2005 280 37803 37813. doi: 10.1074/jbc.M503897200
38. Santos RA, Angiotensin-(1-7). Hypertension 2014 63 1138 1147. doi: 10.1161/HYPERTENSIONAHA.113.01274
39. Mendes AC, Ferreira AJ, Pinheiro SV, Santos RA, Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats. Regul Pept 2005 125 29 34. doi: 10.1016/j.regpep.2004.07.023
40. Passos-Silva DG, Verano-Braga T, Santos RA, Angiotensin-(1-7): beyond the cardio-renal actions. Clin Sci (Lond) 2013 124 443 456. doi: 10.1042/CS20120461